FPRT Bio is a biotechnology company developing inhibitors of inflammation for diseases ranging from rheumatoid arthritis to ALS and Alzheimerâs Disease. The company is focused on therapeutics with new mechanisms to inhibit TNF-α, and is developing a lead molecule, XPro1595, for clinical trials in neurological disorders. Xpro1595 is a protein therapeutic that targets tumor necrosis factor (TNF-α) by a novel mechanism not available to currently approved anti-TNF therapeutic